Cover Image
市場調查報告書

Physica Pharma的產品平台分析

Physica Pharma - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 219744
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Physica Pharma的產品平台分析 Physica Pharma - Product Pipeline Review - 2014
出版日期: 2014年09月10日 內容資訊: 英文 21 Pages
簡介

Physica Pharma是總公司位於法國的製藥企業,透過注射器型口服藥、噴鼻劑、經皮給藥等技術平台,來設計、研究開發藥物遞輸系統產品。

本報告提供Physica Pharma的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Physica Pharma的基本資料

  • Physica Pharma概要
  • 主要資訊
  • 企業資料

Physica Pharma:R&D概要

  • 主要的治療範圍

Physica Pharma:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Physica Pharma:開發中產品概況

  • 初期階段產品開發中產品
    • 藥物研發中的產品/聯合治療模式
  • 開發階段不明的產品
    • 開發階段不明的產品/聯合治療模式

Physica Pharma:藥物簡介

  • PHY-303
  • PHY-702
  • PHY-705
  • PHY-301
  • PHY-510

Physica Pharma:開發平台分析

  • 各作用機制
  • 各分子類型

Physica Pharma:開發暫停中的計劃

Physica Pharma:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06408CDB

Summary

Global Markets Direct's, 'Physica Pharma - Product Pipeline Review - 2014', provides an overview of the Physica Pharma's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Physica Pharma's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Physica Pharma including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Physica Pharma's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Physica Pharma's pipeline products

Reasons to buy

  • Evaluate Physica Pharma's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Physica Pharma in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Physica Pharma's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Physica Pharma and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Physica Pharma
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Physica Pharma and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Physica Pharma Snapshot
    • Physica Pharma Overview
    • Key Information
    • Key Facts
  • Physica Pharma - Research and Development Overview
    • Key Therapeutic Areas
  • Physica Pharma - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Physica Pharma - Pipeline Products Glance
    • Physica Pharma - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
    • Physica Pharma - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Physica Pharma - Drug Profiles
    • PHY-303
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHY-702
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHY-705
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHY-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHY-510
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Physica Pharma - Pipeline Analysis
    • Physica Pharma - Pipeline Products by Route of Administration
    • Physica Pharma - Pipeline Products by Molecule Type
  • Physica Pharma - Dormant Projects
  • Physica Pharma - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Physica Pharma, Key Information
  • Physica Pharma, Key Facts
  • Physica Pharma - Pipeline by Indication, 2014
  • Physica Pharma - Pipeline by Stage of Development, 2014
  • Physica Pharma - Monotherapy Products in Pipeline, 2014
  • Physica Pharma - Discovery, 2014
  • Physica Pharma - Unknown, 2014
  • Physica Pharma - Pipeline by Route of Administration, 2014
  • Physica Pharma - Pipeline by Molecule Type, 2014
  • Physica Pharma - Dormant Developmental Projects,2014

List of Figures

  • Physica Pharma - Pipeline by Top 10 Indication, 2014
  • Physica Pharma - Pipeline by Stage of Development, 2014
  • Physica Pharma - Monotherapy Products in Pipeline, 2014
  • Physica Pharma - Pipeline by Top 10 Route of Administration, 2014
Back to Top